Back
Aldeyra Therapeutics, Inc. Stock Predictions
Still Time to Get In: RAD Intel at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
40
ALDX
Aldeyra Therapeutics, Inc.
Last Price:
$4.87
Seasonality Move:
5.87%
7 Day Trial
ALL ACCESS PASS
$
7
Missed $0.81? RAD Intel Now Open at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiAldeyra Therapeutics, Inc. Stock Forecast
-
Is Aldeyra Therapeutics, Inc. Stock Undervalued?The current Aldeyra Therapeutics, Inc. [ALDX] share price is $4.87. The Score for ALDX is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
-
ALDX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Aldeyra Therapeutics, Inc. Stock Go Up Next Year?
Data Unavailable
Aldeyra Therapeutics, Inc. Stock Rating
Data Unavailable
Aldeyra Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
aldeyra.com
52-Week Data
52-Week High:
7.20
52-Week Low:
1.14
Prediction Charts
Market Cap:
293M
Price in USD:
4.87
Volume:
1.5M
Beta:
1.25
Technical Analysis
SMA50:
5.20
SMA100:
5.28
SMA200:
4.58
52-Wk Change:
2.74%
Stock Predictions
-
Is Aldeyra Therapeutics, Inc. stock public?Yes, Aldeyra Therapeutics, Inc. is a publicly traded company.
-
What is the Aldeyra Therapeutics, Inc. stock quote today?The Aldeyra Therapeutics, Inc. stock price is 4.87 USD today.
-
How to buy Aldeyra Therapeutics, Inc. stock online?You can buy Aldeyra Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-13 | 5.27 | 5.02 | 5.27 | 4.99 |
| Nov-14 | 4.94 | 5.05 | 5.19 | 4.92 |
| Nov-17 | 5.05 | 4.95 | 5.14 | 4.85 |
| Nov-18 | 4.95 | 4.91 | 4.99 | 4.80 |
| Nov-19 | 4.89 | 4.86 | 4.93 | 4.73 |
| Nov-20 | 4.99 | 4.73 | 5.04 | 4.71 |
| Nov-21 | 4.71 | 4.96 | 5.07 | 4.70 |
| Nov-24 | 4.97 | 5.23 | 5.30 | 4.95 |
| Nov-25 | 5.25 | 5.26 | 5.35 | 5.18 |
| Nov-26 | 5.27 | 5.59 | 5.65 | 5.23 |
| Nov-28 | 5.55 | 5.48 | 5.68 | 5.45 |
| Dec-1 | 5.42 | 5.24 | 5.46 | 5.19 |
| Dec-2 | 5.22 | 4.87 | 5.25 | 4.84 |
| Dec-3 | 4.97 | 4.87 | 5.05 | 4.71 |
Aldeyra Therapeutics, Inc. Earnings
Data Unavailable
Aldeyra Therapeutics, Inc. Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.32 per share, and an increase next year of $1.14 per share.
* Aldeyra Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.